Suchergebnisse - "Sandler, Howard M"

PubPharm (415)

1

A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer

enthalten in: Cancer | 2024

von Solanki, A. | Kamrava, M. | Posadas, E. | +6

2

Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms : The NRG-GU003 Phase 3 Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Buyyounouski, M. | Pugh, S. | Chen, R. | +18

ErratumIn: JAMA Oncol. 2024 Apr 18;:. - PMID 38635236

3

Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation

enthalten in: European urology oncology | 2024

von Dahl, D. | Karrison, T. | Michaelson, M. | +15

4

Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer : Long-term Update of NRG/RTOG 9202

enthalten in: European urology focus | 2024

von Mak, K. | Scannell Bryan, M. | Dignam, J. | +20

5

External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial

enthalten in: European urology oncology | 2024

von Ross, A. | Zhang, J. | Huang, H. | +27

6

Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels : A Meta-Analysis

enthalten in: JAMA network open | 2023

von Mahal, B. | Kwak, L. | Xie, W. | +9

7

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer : Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial

enthalten in: International journal of radiation oncology, biology, physics | 2023

von Spratt, D. | Liu, V. | Michalski, J. | +18

8

Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer : NRG Oncology RTOG 0232 Randomized Clinical Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Michalski, J. | Winter, K. | Prestidge, B. | +17

9

Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer : Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial

enthalten in: European urology | 2023

von Sartor, O. | Karrison, T. | Sandler, H. | +17

CommentIn: Eur Urol. 2023 Aug;84(2):164-165. - PMID 37270389

10

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer

enthalten in: NEJM evidence | 2023

von Spratt, D. | Tang, S. | Sun, Y. | +25

UpdateOf: Res Sq. 2023 Apr 21;:. - PMID 37131691

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[42]